reproductive health
Which state ranks highest for women's health care?
.png?width=1252&height=922&upscale=true&name=uUq5G-all-cause-mortality-highest-in-the-southeast%20(1).png)
The Commonwealth Fund released a report today ranking states in the U.S. for women's health and reproductive care. The scorecard comes at a time when reproductive care — especially abortion — is increasingly restricted in states across the country. Here are some key takeaways:
- The report ranks Massachusetts as the best-performing health system for women overall, with Vermont, Rhode Island, Connecticut, and New Hampshire coming in next.
- The lowest-ranked states were Mississippi, Texas, Nevada, Oklahoma, and Arkansas.
- Maternal mortality is worst in the Mississippi Delta region, where many people live in maternity care deserts without hospitals or birth centers.
- States with abortion restrictions typically have the fewest number of maternity care providers.
cancer
What if bone marrow donors didn't need to be a perfect match after all?
A bone marrow transplant can be somebody's last chance at a life-saving cure for many blood cancers, but most patients of non-European ancestry don't find a perfect bone marrow donor match. Without a perfect match — meaning the donor cells match the recipient's on eight key immune markers — there's a greater chance of dangerous complications and worse efficacy. But a new study suggests outcomes are similar if donors match recipients on only seven of those markers, as long as the right drugs are used.
"Back when I was a fellow, outcomes were dismal when patients got an unmatched donor," Brian Shaffer, lead author on the study, said to STAT's Angus Chen. If that can change, it would substantially reduce racial health disparities in these cancers. Read more from Angus on the science.
coronavirus
One action that helps lower risk of long Covid: Study
Vaccination lowers the odds of developing long Covid, according to a study published yesterday in the New England Journal of Medicine. The research also found that the risk of serious complications from long Covid diminished but didn't disappear as the delta and omicron variants of the virus emerged. STAT's Liz Cooney has more on the study and how unvaccinated patients fared in comparison to those who got the shot.
STAT's Isa Cueto also flagged another study about long Covid, published yesterday in Science Translational Medicine. This one identifies a signaling molecule that may be a key driver of symptoms in the lungs. But what Isa found notable is that for people with respiratory symptoms, fluid from their lungs showed signs of sustained immune activation — lending further support to recent research that found inflammation and other evidence of the Covid virus in patients years after initial infection.
No comments